Cytek Biosciences, Inc. (CTKB)
NASDAQ: CTKB · Real-Time Price · USD
3.770
-0.210 (-5.28%)
At close: Jun 18, 2026, 4:00 PM EDT
3.771
+0.001 (0.02%)
After-hours: Jun 18, 2026, 7:12 PM EDT
Cytek Biosciences Market Cap
Cytek Biosciences has a market cap or net worth of $486.87 million as of June 18, 2026. Its market cap has increased by 13.06% in one year.
Market Cap
486.87M
Enterprise Value
252.12M
1-Year Change
13.06%
Ranking
Category
Stock Price
$3.77
Market Cap Chart
Since the IPO on July 23, 2021, Cytek Biosciences's market cap has decreased from $2.26B to $486.87M, a decrease of -78.47%. That is a compound annual growth rate of -26.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 486.87M | -24.60% |
| Dec 31, 2025 | 645.72M | -22.76% |
| Dec 31, 2024 | 835.98M | -32.38% |
| Dec 29, 2023 | 1.24B | -10.21% |
| Dec 30, 2022 | 1.38B | -36.91% |
| Dec 31, 2021 | 2.18B | -3.47% |
| Jul 23, 2021 | 2.26B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tactile Systems Technology | 600.45M |
| BrainsWay | 574.00M |
| Cerus | 541.00M |
| ClearPoint Neuro | 532.91M |
| NeuroPace | 532.89M |
| OrthoPediatrics | 484.68M |
| Mobia Medical | 471.47M |
| Varex Imaging | 444.22M |